• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝 Slug 通过表观遗传促进肝脏脂肪生成、脂肪肝疾病和 2 型糖尿病。

Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes.

机构信息

Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.

出版信息

J Clin Invest. 2020 Jun 1;130(6):2992-3004. doi: 10.1172/JCI128073.

DOI:10.1172/JCI128073
PMID:32365055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7260003/
Abstract

De novo lipogenesis is tightly regulated by insulin and nutritional signals to maintain metabolic homeostasis. Excessive lipogenesis induces lipotoxicity, leading to nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Genetic lipogenic programs have been extensively investigated, but epigenetic regulation of lipogenesis is poorly understood. Here, we identified Slug as an important epigenetic regulator of lipogenesis. Hepatic Slug levels were markedly upregulated in mice by either feeding or insulin treatment. In primary hepatocytes, insulin stimulation increased Slug expression, stability, and interactions with epigenetic enzyme lysine-specific demethylase-1 (Lsd1). Slug bound to the fatty acid synthase (Fasn) promoter where Slug-associated Lsd1 catalyzed H3K9 demethylation, thereby stimulating Fasn expression and lipogenesis. Ablation of Slug blunted insulin-stimulated lipogenesis. Conversely, overexpression of Slug, but not a Lsd1 binding-defective Slug mutant, stimulated Fasn expression and lipogenesis. Lsd1 inhibitor treatment also blocked Slug-stimulated lipogenesis. Remarkably, hepatocyte-specific deletion of Slug inhibited the hepatic lipogenic program and protected against obesity-associated NAFLD, insulin resistance, and glucose intolerance in mice. Conversely, liver-restricted overexpression of Slug, but not the Lsd1 binding-defective Slug mutant, had the opposite effects. These results unveil an insulin/Slug/Lsd1/H3K9 demethylation lipogenic pathway that promotes NAFLD and type 2 diabetes.

摘要

从头合成脂是受胰岛素和营养信号的严格调节,以维持代谢平衡。过度的从头合成脂会引起脂毒性,导致非酒精性脂肪性肝病(NAFLD)和 2 型糖尿病。遗传的脂生成程序已经得到了广泛的研究,但脂生成的表观遗传调控知之甚少。在这里,我们发现 Slug 是脂生成的一个重要的表观遗传调控因子。无论是通过喂养还是胰岛素处理,小鼠肝脏中的 Slug 水平都明显上调。在原代肝细胞中,胰岛素刺激增加了 Slug 的表达、稳定性和与表观遗传酶赖氨酸特异性去甲基化酶-1(Lsd1)的相互作用。Slug 结合到脂肪酸合成酶(Fasn)启动子上,Slug 相关的 Lsd1 在此处催化 H3K9 去甲基化,从而刺激 Fasn 的表达和脂生成。Slug 的缺失削弱了胰岛素刺激的脂生成。相反,Slug 的过表达,而不是 Lsd1 结合缺陷的 Slug 突变体,刺激 Fasn 的表达和脂生成。Lsd1 抑制剂治疗也阻断了 Slug 刺激的脂生成。值得注意的是,肝细胞特异性缺失 Slug 抑制了肝脂生成程序,并防止肥胖相关的 NAFLD、胰岛素抵抗和葡萄糖不耐受在小鼠中发生。相反,肝脏特异性过表达 Slug,而不是 Lsd1 结合缺陷的 Slug 突变体,产生了相反的效果。这些结果揭示了一个胰岛素/Slug/Lsd1/H3K9 去甲基化的脂生成途径,它促进了 NAFLD 和 2 型糖尿病的发生。

相似文献

1
Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes.肝 Slug 通过表观遗传促进肝脏脂肪生成、脂肪肝疾病和 2 型糖尿病。
J Clin Invest. 2020 Jun 1;130(6):2992-3004. doi: 10.1172/JCI128073.
2
Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis.胰岛素/蜗牛 1 轴通过表观遗传抑制脂肪生成来改善脂肪肝疾病。
Nat Commun. 2018 Jul 16;9(1):2751. doi: 10.1038/s41467-018-05309-y.
3
Insulin-stimulated lipogenesis gets an epigenetic makeover.胰岛素刺激的脂肪生成获得表观遗传修饰。
J Clin Invest. 2020 Jun 1;130(6):2809-2810. doi: 10.1172/JCI137050.
4
Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.组蛋白 H3K9 去甲基酶 JMJD2B 在 LXRα 依赖性脂肪生成中发挥作用。
Int J Mol Sci. 2020 Nov 5;21(21):8313. doi: 10.3390/ijms21218313.
5
Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD.脂肪酸合酶抑制剂筛选确定分选衔接蛋白8为非酒精性脂肪性肝病的治疗靶点。
Hepatology. 2021 Nov;74(5):2508-2525. doi: 10.1002/hep.32045. Epub 2021 Sep 21.
6
Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models.肝 FASN 缺乏症在肥胖症小鼠模型中对非酒精性脂肪肝和糖尿病的影响不同。
JCI Insight. 2023 Sep 8;8(17):e161282. doi: 10.1172/jci.insight.161282.
7
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.通过胰高血糖素依赖途径,KCTD17介导的PHLPP2降解促进肝脂肪变性。
Gastroenterology. 2017 Dec;153(6):1568-1580.e10. doi: 10.1053/j.gastro.2017.08.039. Epub 2017 Aug 30.
8
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.藏红花酸通过激活 db/db 小鼠的 AMPK 信号通路改善肝脂肪变性。
Lipids Health Dis. 2019 Jan 8;18(1):11. doi: 10.1186/s12944-018-0955-6.
9
LepRb+ cell-specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice.LepRb+ 细胞特异性敲除 Slug 可减轻肥胖和非酒精性脂肪性肝病小鼠的病情。
J Clin Invest. 2023 Feb 15;133(4):e156722. doi: 10.1172/JCI156722.
10
The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.脂肪细胞因子 sFRP4 可诱导肝脏胰岛素抵抗和脂肪生成。
Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2671-2684. doi: 10.1016/j.bbadis.2019.07.008. Epub 2019 Jul 20.

引用本文的文献

1
Orchestration of Gut-Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation.非酒精性脂肪性肝病中肠道-肝脏相关转录因子的调控:从跨器官相互作用到治疗创新
Biomedicines. 2025 Jun 10;13(6):1422. doi: 10.3390/biomedicines13061422.
2
METTL14-Induced MA Methylation Increases G6pc Biosynthesis, Hepatic Glucose Production and Metabolic Disorders in Obesity.METTL14诱导的甲基化增加肥胖症中的G6pc生物合成、肝葡萄糖生成及代谢紊乱。
Adv Sci (Weinh). 2025 Jun;12(22):e2417355. doi: 10.1002/advs.202417355. Epub 2025 Apr 25.
3
Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook.推进代谢功能障碍相关脂肪性肝病蛋白质组学:翻译后修饰视角
Genes (Basel). 2025 Mar 12;16(3):334. doi: 10.3390/genes16030334.
4
Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism.FLAD1的拷贝数扩增通过脂质代谢促进三阴性乳腺癌的进展。
Nat Commun. 2025 Feb 1;16(1):1241. doi: 10.1038/s41467-025-56458-w.
5
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism.代谢功能障碍相关脂肪性肝病的发病机制:脂质代谢的重要作用。
J Clin Transl Hepatol. 2024 Sep 28;12(9):815-826. doi: 10.14218/JCTH.2024.00019. Epub 2024 Sep 3.
6
Epithelial-mesenchymal transition in tissue repair and degeneration.组织修复与退变中的上皮-间质转化
Nat Rev Mol Cell Biol. 2024 Sep;25(9):720-739. doi: 10.1038/s41580-024-00733-z. Epub 2024 Apr 29.
7
Hepatic Snai1 and Snai2 promote liver regeneration and suppress liver fibrosis in mice.Snai1 和 Snai2 在促进小鼠肝脏再生和抑制肝纤维化中的作用。
Cell Rep. 2024 Mar 26;43(3):113875. doi: 10.1016/j.celrep.2024.113875. Epub 2024 Mar 6.
8
Surplus fatty acid synthesis increases oxidative stress in adipocytes and lnduces lipodystrophy.过剩脂肪酸的合成会增加脂肪细胞的氧化应激,导致脂肪营养不良。
Nat Commun. 2024 Jan 2;15(1):133. doi: 10.1038/s41467-023-44393-7.
9
Histone Modifications in NAFLD: Mechanisms and Potential Therapy.非酒精性脂肪性肝病中组蛋白修饰:机制与潜在治疗策略。
Int J Mol Sci. 2023 Sep 27;24(19):14653. doi: 10.3390/ijms241914653.
10
OVOL2: an epithelial lineage determiner with emerging roles in energy homeostasis.OVOL2:一种上皮谱系决定因子,在能量平衡中具有新兴作用。
Trends Cell Biol. 2023 Oct;33(10):824-833. doi: 10.1016/j.tcb.2023.05.008. Epub 2023 Jun 17.

本文引用的文献

1
Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis.胰岛素/蜗牛 1 轴通过表观遗传抑制脂肪生成来改善脂肪肝疾病。
Nat Commun. 2018 Jul 16;9(1):2751. doi: 10.1038/s41467-018-05309-y.
2
Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.肝神经调节素 4 信号定义了脂肪变性向 NASH 进展的内分泌检查点。
J Clin Invest. 2017 Dec 1;127(12):4449-4461. doi: 10.1172/JCI96324. Epub 2017 Nov 6.
3
Liver NF-κB-Inducing Kinase Promotes Liver Steatosis and Glucose Counterregulation in Male Mice With Obesity.肝脏核因子κB诱导激酶促进肥胖雄性小鼠的肝脏脂肪变性和葡萄糖反调节。
Endocrinology. 2017 May 1;158(5):1207-1216. doi: 10.1210/en.2016-1582.
4
Adipose Snail1 Regulates Lipolysis and Lipid Partitioning by Suppressing Adipose Triacylglycerol Lipase Expression.脂肪蜗牛1通过抑制脂肪甘油三酯脂肪酶的表达来调节脂肪分解和脂质分配。
Cell Rep. 2016 Nov 15;17(8):2015-2027. doi: 10.1016/j.celrep.2016.10.070.
5
Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation.Snail/Slug与YAP/TAZ的结合相互作用调控骨骼干细胞的自我更新和分化。
Nat Cell Biol. 2016 Sep;18(9):917-29. doi: 10.1038/ncb3394. Epub 2016 Aug 1.
6
LSD1 Interacts with Zfp516 to Promote UCP1 Transcription and Brown Fat Program.赖氨酸特异性去甲基化酶1(LSD1)与锌指蛋白516(Zfp516)相互作用以促进解偶联蛋白1(UCP1)转录和棕色脂肪生成程序。
Cell Rep. 2016 Jun 14;15(11):2536-49. doi: 10.1016/j.celrep.2016.05.019. Epub 2016 Jun 2.
7
E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.E4BP4是一种胰岛素诱导的核SREBP-1c稳定剂,可促进SREBP-1c介导的脂肪生成。
J Lipid Res. 2016 Jul;57(7):1219-30. doi: 10.1194/jlr.M067181. Epub 2016 Jun 1.
8
E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.E2F1介导持续的脂肪生成并导致肝脂肪变性。
J Clin Invest. 2016 Jan;126(1):137-50. doi: 10.1172/JCI81542. Epub 2015 Nov 30.
9
Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.肥胖人群体重增加所致脂肪变性的生理机制
Gastroenterology. 2016 Jan;150(1):79-81.e2. doi: 10.1053/j.gastro.2015.09.003. Epub 2015 Sep 12.
10
A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.一种代谢应激诱导的miR-34a-HNF4α途径调节脂质和脂蛋白代谢。
Nat Commun. 2015 Jun 23;6:7466. doi: 10.1038/ncomms8466.